Search Results - "Athanassiades, A"

Vascular Endothelial Growth Factor Stimulates Proliferation but Not Migration or Invasiveness in Human Extravillous Trophoblast by ATHANASSIADES, A, HAMILTON, G. S, LALA, P. K

“…Vascular endothelial growth factor (VEGF) is a homodimeric glycoprotein that promotes angiogenesis and vascular hyperpermeability and interacts with two…”
Get full text

Role of placenta growth factor (PIGF) in human extravillous trophoblast proliferation, migration and invasiveness by ATHANASSIADES, A, LALA, P. K

“…Placenta growth factor (PlGF) is a homodimeric glycoprotein, 46-50 kDa in size, belonging to the vascular endothelial growth factor (VEGF) sub-family. It…”
Get full text

A phase II study of paclitaxel in advanced breast cancer resistant to anthracyclines by Fountzilas, G., Athanassiades, A., Giannakakis, T., Bafaloukos, D., Karakousis, K., Dombros, N., Kosmidis, P., Skarlos, D.

“…33 women with advanced breast cancer resistant to anthracyclines were treated with paclitaxel 175 mg/m 2 in a 3 h infusion every 3 weeks. The median age was 53…”
Get full text

Paclitaxel by three-hour infusion and carboplatin in advanced carcinoma of nasopharynx and other sites of the head and neck : A phase II study conducted by the Hellenic Cooperative Oncology Group by FOUNTZILAS, G, SKARLOS, D, STATHOPOULOS, G, PAVLIDIS, N, KOSMIDIS, P, DANIILIDIS, J, ATHANASSIADES, A, KALOGERA-FOUNTZILA, A, SAMANTAS, E, BACOYIANNIS, C, NICOLAOU, A, DOMBROS, N, BRIASOULIS, E, DINOPOULOU, M

“…Paclitaxel has been demonstrated to have significant activity in recurrent or metastatic head and neck cancer (HNC). In addition, the combination of paclitaxel…”
Get full text

Role of placenta prowth factor (PIGF) in human extravillous trophoblast proliferation, migration and invasiveness by Athanassiades, A., Lala, P.K.

“…Placenta growth factor (PIGF) is a homodimeric glycoprotein, 46–50 kDa in size, belonging to the vascular endothelial growth factor (VEGF) sub-family. It…”
Get full text

First-line chemotherapy with paclitaxel by three-hour infusion and carboplatin in advanced breast cancer (final report): A phase II study conducted by the Hellenic Cooperative Oncology Group by Fountzilas, G., Dimopoulos, A.-M., Papadimitriou, C., Kalogera-Fountzila, A., Aravantinos, G., Bafaloukos, D., Athanassiades, A., Nicolaides, C., Keramopoulos, A., Pavlidis, N., Kosmidis, P., Skarlos, D.

“…Purpose: To evaluate the activity and toxicity of the combination of paclitaxel given by three-hour infusion, and carboplatin as first-line chemotherapy in…”
Get full text

A randomized study of epirubicin monotherapy every four or every two weeks in advanced breast cancer. A Hellenic Cooperative Oncology Group study by Fountzilas, G., Athanassiades, A., Giannakakis, T., Briasoulis, E., Bafaloukos, D., Kalogera-Fountzila, A., Onienaoum, A., Kalofonos, H., Pectasides, D., Andreopoulou, E., Bamia, C., Kosmidis, P., Pavlidis, N., Skarlos, D.

“…Purpose To evaluate the impact on the response rate in patients with advanced breast cancer (ABC) of the doubling of the dose intensity (DI) of epirubicin…”
Get full text

Association study between the dopamine D4 receptor gene and schizophrenia by Petronis, A, Macciardi, F, Athanassiades, A, Paterson, A D, Verga, M, Meltzer, H Y, Cola, P, Buchanan, J A, Van Tol, H H, Kennedy, J L

“…The dopamine D4 receptor is of major interest in schizophrenia research due to its high affinity for the atypical neuroleptic clozapine and a high degree of…”
Get more information

Paclitaxel in combination with carboplatin or gemcitabine for the treatment of advanced head and neck cancer by Fountzilas, G, Athanassiades, A, Kalogera-Fountzila, A, Samantas, E, Bacoyiannis, C, Briassoulis, E, Pavlidis, N, Kosmidis, P, Skarlos, D

“…We performed a phase II study to evaluate the activity and toxicity of the combination of paclitaxel (Taxol; Bristol-Myers Squibb Company, Princeton, NJ) and…”
Get more information

A phase II study of paclitaxel in platinum pretreated ovarian cancer. A hellenic cooperative oncology group study by Aravantinos, G., Skarlos, D.V., Kosmidis, P., Athanassiades, A., Bafaloukos, D., Giannakakis, T., Karpathios, S., Fountzilas, G.

“…Paclitaxel was administered at a dose of 175 mg/m 2 in a 3-hour infusion every 3 weeks in platinum pretreated patients with ovarian cancer. 51 patients with a…”
Get full text

A "Coupled" Subchondral Bone-Articular Cartilage Tissue Culture System for the Study of Cartilage Proteoglycan Metabolism by Athanassiades, A, Anastassiades, T P

“…Current evidence suggests that interactions between the subchondral bone and the articular cartilage of mammalian diarthrodial joints may occur through the…”
Get full text

Hybridization of multiply loaded microsatellites does not require nested primers by Petronis, A, Athanassiades, A, Kennedy, J L

Get more information

The influence of cefuroxime and ampicillin on uterus contractility by Kouvelas, D, Athanassiades, A, Argyriou, A, Crassaris, L G, Paradelis, A G

Get more information

Vascular Endothelial Growth Factor Stimulates Proliferation but Not Migration or Invasiveness in Human Extravillous Trophoblast1 by Athanassiades, A., Hamilton, G.S., Lala, P.K.

Get full text

VEGF is an autocrine/paracrine growth-stimulatory factor for normal and SV40 tag-immortalized extravillous trophoblast cells by Athanassiades, A., Hamilton, G.S., Lala, P.K.

Get full text

A "coupled" subchondral bone-articular cartilage tissue culture system for the study of cartilage proteoglycan metabolism by Athanassiades, A, Anastassiades, T P

“…Current evidence suggests that interactions between the subchondral bone and the articular cartilage of mammalian diarthrodial joints may occur through the…”
Get full text

Paclitaxel and carboplatin as first-line chemotherapy for advanced breast cancer by Fountzilas, G, Athanassiades, A, Papadimitriou, V, Dimopoulos, M A, Bafaloukos, D, Aravantinos, G, Nicolaides, C, Kalofonos, H, Papakostas, P, Xiros, N, Razi, E

“…In a phase II study, 66 patients with advanced breast cancer (median age 56 years; range, 28 to 75 years) were treated with paclitaxel (Taxol), 175 mg/m2…”
Get more information

504 Early vs late bifractionated chest irradiation concurrently with chemotherapy in limited disease (LD) small-cell lung cancer (SCLC) (Preliminary results) by Samantas, E., Fountzilas, G., Athanassiades, A., Pavlidis, N., Nikolaides, C., Panousaki, E., Kalofonos, C., Tsiakopoulos, E., Kosmas, E., Kiamouris, C., Skarios, D.

Get full text

Paclitaxel by three-hour infusion and carboplatin in advanced carcinoma of nasopharynx and other sites of the head and neck by Fountzilas, G., Skarlos, D., Athanassiades, A., Kalogera-Fountzila, A., Samantas, E., Bacoyiannis, C., Nicolaou, A., Dombros, N., Briasoulis, E., Dinopoulou, M., Stathopoulos, G., Pavlidis, N., Kosmidis, P., Daniilidis, N.

“…Background: Paclitaxel has been demonstrated to have significant activity in recurrent or metastatic head and neck cancer (HNC). In addition, the combination…”
Get full text